News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 831
- Sources here
- 18
- Companies here
- 18
Active search
831 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Nayax (NASDAQ: NYAX) reports 276 CSO shares sold for RSU tax withholding
Nayax Ltd.'s Chief Strategy Officer, Aaron Samuel Greenberg, reported the sale of 276 ordinary shares on August 3, 2026, to cover tax withholding obligations related to restricted share unit vesting. The shares were sold in two separate transactions at weighted average prices of $68.2029 …
BBVA Closes EUR1.5 Billion Share Buyback Tranche
BBVA has successfully completed a share buyback program totaling EUR1.5 billion. This action is part of the bank's strategy to return capital to shareholders. The buyback involved the acquisition of a significant number of shares, which are expected to be cancelled.
Pagaya Technologies (PGY) president sells 21,289 shares at $22
Sanjiv Das, President of Pagaya Technologies Ltd. (PGY), sold 21,289 Class A Ordinary Shares at a price of $22.00 per share on August 3, 2026. Following this transaction, his direct ownership in the company stands at 144,185.5380 Class A shares. The sale, classified as …
Pagaya Technologies (PGY) director logs equity award and 28,181-share sale
Pagaya Technologies Ltd. director Tami Rosen reported an equity award and a share sale on August 3, 2026. Rosen received 7,302 Class A Ordinary Shares, consisting of immediately vested shares and restricted stock units, and sold 28,181 Class A Ordinary Shares at a weighted …
Nayax (NYAX) insider Aaron Greenberg files to sell shares and receive RSU stock
Nayax Ltd. insider Aaron Greenberg has filed to sell 276 Ordinary Shares valued at $18,842.52 through Oppenheimer & Co. Inc. on August 3, 2026. On the same date, 5,500 Ordinary Shares are scheduled to be issued to Greenberg upon the vesting of Restricted Stock …
IDEAYA Posts Q2 Loss as Cash Reaches $1.24 Billion
IDEAYA Biosciences (IDYA) reported a Q2 2026 net loss of $112.5 million ($1.22 per share) on collaboration revenue of $8.9 million, up from the prior quarter. The company announced its cash, cash equivalents, and marketable securities reached $1.24 billion, with cash runway guidance into …
IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
IDEAYA Biosciences announced its second-quarter 2026 financial results and provided a business update. The company's registrational OptimUM-02 trial for darovasertib combination in metastatic uveal melanoma met its primary endpoint, with an NDA filing underway. IDEAYA also reported a strong financial position with approximately $1.24 …
IDEAYA Biosciences reports Q2 2026 net loss $112.5M; cash $1.24B after $323M offering
IDEAYA Biosciences reported a net loss of $112.5 million for Q2 2026, ending the period with $1.24 billion in cash, cash equivalents, and marketable securities after a $323 million public offering. The company's OptimUM-02 trial met its primary endpoint, leading to an NDA filing …
IDEAYA Biosciences Q2 Loss Widens From Q1, Revenue Rises
IDEAYA Biosciences (IDYA) reported a wider loss of $1.22 per diluted share in Q2, compared to the previous quarter. Despite the increased loss, the company experienced a rise in revenue during the same period. This article provides a brief overview of IDEAYA's Q2 financial …
Behavioral Patterns of NYAX and Institutional Flows
This article analyzes Nayax Ltd. (NASDAQ: NYAX) with key findings indicating weak near-term sentiment but strong mid and long-term outlooks. It details AI-generated trading strategies including position, momentum, and risk hedging, alongside multi-timeframe signal analysis for various risk profiles. The report highlights an exceptional …
European Growth Stocks With High Insider Ownership
The European market is experiencing a positive trend, with the STOXX Europe 600 Index reaching new highs, supported by strong corporate earnings and interest in AI stocks. This environment highlights growth companies with high insider ownership as appealing investments due to aligned management and …
Earnings Flash (IDYA) IDEAYA Biosciences, Inc. Reports Q2 Revenue $8.9M, vs. FactSet Est of $8.0M
IDEAYA Biosciences, Inc. (IDYA) announced its Q2 revenue of $8.9 million, surpassing FactSet's estimate of $8.0 million. This news comes alongside other recent updates for the company, including Wedbush adjusting its price target to $60 and maintaining an Outperform rating, and the company's Q2 …
Lazard Asset Management LLC Has $1.95 Million Stock Holdings in Electrovaya Inc. $ELVA
Lazard Asset Management LLC significantly increased its stake in Electrovaya Inc. (NASDAQ:ELVA) by 188.9% in the first quarter, now holding 249,429 shares valued at approximately $1.95 million. Institutional investors collectively own 22.47% of ELVA, and analysts maintain a "Moderate Buy" rating with an average …
Sharemaestro market context Price below Trend Line 52 weeks +69.5% · Next-week setup negative 44.7%EBIT of Pagaya Technologies Ltd Class A – BMV:PGY/N
This page displays the EBIT (Earnings Before Interest and Taxes) for Pagaya Technologies Ltd Class A (PGY/N) on the Mexican Stock Exchange. The market is currently closed, and no trades are available. The content includes a brief financial overview and states that the data …
Dimensional Fund Advisors LP Increases Position in IDEAYA Biosciences, Inc. $IDYA
Dimensional Fund Advisors LP significantly increased its stake in IDEAYA Biosciences, Inc. (IDYA) by 42% in Q1, now holding 1.33 million shares valued at $44.4 million. Other institutional investors like State Street and Janus Henderson also boosted their positions, with institutional ownership reaching 98.29%. …
Nayax (NYAX) Projected to Announce Quarterly Earnings on Monday
Nayax (NYAX) is expected to report its Q2 2026 earnings on Monday, August 10th, with analysts forecasting earnings of $0.09 per share and revenue of $116.75 million. The company's previous quarter results missed EPS estimates but exceeded revenue expectations. Nayax shares recently traded at …
Sharemaestro market context Trend signal ended 52 weeks -3.0% · Next-week setup positive 64.1%